Provided by Tiger Trade Technology Pte. Ltd.

NovaBay Pharmaceuticals

1.16
-0.0600-4.92%
Volume:132.57K
Turnover:157.97K
Market Cap:30.89M
PE:-0.30
High:1.25
Open:1.22
Low:1.16
Close:1.22
52wk High:99.75
52wk Low:1.11
Shares:26.63M
Float Shares:2.62M
Volume Ratio:0.10
T/O Rate:5.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8043
EPS(LYR):-12.6737
ROE:-516.26%
ROA:-76.11%
PB:-1.33
PE(LYR):-0.09

Loading ...

Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 10, 2024

Major Issues Report

Form 8-K - Current report
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 02, 2023

Correspondence

Form CORRESP - Correspondence
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 07, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Correspondence

Form CORRESP - Correspondence
Jun 06, 2023

Correspondence

Form CORRESP - Correspondence
May 31, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 31, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 18, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 18, 2023

Correspondence

Form CORRESP - Correspondence